(PharmaNewsWire.Com, September 22, 2017 ) The Middle East and Africa Platelet Aggregation Devices Market was worth USD 12.8 million in 2016 and is estimated to be growing at a CAGR of 15.5%, to reach USD 26.3 million by 2021. Platelet aggregation is the process in which platelets in the blood clump together to form blood clots at the site of vascular injury with the help of other adhesion factors. This process plays a major role in achieving homeostasis at the time of injuries.
Abnormalities occur in the blood platelets due to some disorders which hinder the clot formation and result in uncontrollable bleeding during injuries. Platelet aggregation tests are conducted using aggregation devices to assess the extent of aggregation and it is very helpful to any abnormalities present before surgical procedures.
Growing number of platelet disorders, technological advancements in aggregation devices and increasing use of antiplatelet therapies are the major factors driving the market growth. Lack of skilled professionals and unaffordable prices of devices in emerging countries are restraining the market growth.
The Middle East and Africa market for platelet aggregation devices is segmented by product, applications, end user and by region. Based on product, the market is segmented into systems, reagents and consumables and accessories. Platelet aggregation systems hold the largest market share due to the increasing automation of aggregation testing procedures. Based on application, the market is segmented into clinical applications and research applications. Clinical applications are again segmented into cardiovascular applications, orthopedic applications and other clinical applications. Clinical applications segment holds the largest market share due to the increased adoption of aggregator devices by healthcare professionals. Based on end user, the market is segmented into standalone hospitals, diagnostic laboratories, research and academic institutes and other end users. Standalone hospitals are expected to hold the largest market share in end users segment due to the increase in platelet disorders and increasing use of platelet therapy for cancer patients.
The platelet aggregation device market in this region is analyzed under Middle East and Africa regions. The market growth is somewhat slow in this region due to the large number of middle and low income countries. However, the market is significantly growing in developing countries such as South Africa.
Major Players in the platelet aggregation devices market are Helena Laboratories Corporation, Haemonetics Corporation, Siemens AG, Sysmex Corporation, Accriva Diagnostics, Sentinel CH. S.p.A., Bio/Data Corporation, Tem Group and Aggredyne, Inc.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
